Program Overview (5 mins)
Key COVID-19 Studies Influencing My Practice Following IDWeek 2021 (30 mins)
- Transmission and vaccines
- Monoclonal antibodies for prevention and treatment
- Direct-acting antivirals
- Long-term COVID-19 outcomes
Question and Answer Session (10 mins)
Date / Time
Arthur Kim, MD
Department of Medicine
Harvard Medical School
Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Massachusetts General Hospital
Renslow Sherer, MD
Director, International HIV Training Center
Professor of Medicine
Section of Infectious Diseases and Global Health
Department of Medicine
University of Chicago
The goal of this activity is to improve learners’ competence in translating the most clinically significant data from IDWeek 2021 into practical management strategies for individuals at risk of or diagnosed with COVID-19.
This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for patients at risk of or diagnosed with COVID-19.
- Integrate new data from studies of vaccines and monoclonal antibodies into prevention strategies for SARS-CoV-2 infection
- Apply safety and efficacy data from recent clinical studies of evolving therapeutics for outpatients and hospitalized patients with COVID-19
Joint Accreditation Statement
In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
CCO designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.75 contact hours.
Continuing Pharmacy Education
CCO designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education. UAN: JA4008176-0000-21-196-L01-P
Type of Activity: Knowledge
Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.
Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.